Načítá se...
The New, New Daptomycin Breakpoint for Enterococcus spp.
In 2019, the Clinical and Laboratory Standards Institute revised the daptomycin breakpoints for Enterococcus spp. twice in rapid succession. Analyses leading to these revisions included review of testing issues, murine and human in vivo pharmacodynamics, safety of off-label doses, and treatment outc...
Uloženo v:
| Vydáno v: | J Clin Microbiol |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Society for Microbiology
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6595459/ https://ncbi.nlm.nih.gov/pubmed/31092593 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.00600-19 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|